The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma
The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
The pursuit of matrix metalloproteinase (MMP) inhibitors began in earnest over three decades ago. Initial clinical trials were disappointing, resulting in a negative view of MMPs as therapeutic targets. As a better understanding of MMP biology and inhibitor pharmacokinetic properties emerged, it became clear that initial MMP inhibitor clinical tria...
Alternative Titles
Full title
The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_30a1b97bd0c94e56af12e7b80f1caea3
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_30a1b97bd0c94e56af12e7b80f1caea3
Other Identifiers
ISSN
2073-4409
E-ISSN
2073-4409
DOI
10.3390/cells8090984
